In the presentation on Monday, RP said they are si
Post# of 148187
(Total Views: 389)
Posted On: 01/30/2019 10:55:42 AM
In the presentation on Monday, RP said they are sitting on $200M dollars of product once approved by the FDA.
Here is the webcast for the NobleCon15 Conference:
http://noble.mediasite.com/mediasite/Play/a08...b6137a611d
Breaking this down, the latest they announced an expected price adjustment to charge $75k per year per patient. I assume that $200M was based on this price, so enough for 2700 patients. NP answered the average cost was $3-4k (see below), which did include twice a week. So the cost I assume was around $11M.
Here is a question from the Jan 2017 CC.
https://seekingalpha.com/article/4034678-cyto...art=single
Here is the webcast for the NobleCon15 Conference:
http://noble.mediasite.com/mediasite/Play/a08...b6137a611d
Breaking this down, the latest they announced an expected price adjustment to charge $75k per year per patient. I assume that $200M was based on this price, so enough for 2700 patients. NP answered the average cost was $3-4k (see below), which did include twice a week. So the cost I assume was around $11M.
Here is a question from the Jan 2017 CC.
https://seekingalpha.com/article/4034678-cyto...art=single
Quote:
Well, can you give us some idea what the relative to us, you said your cost of manufacture is going to be substantially less? Could you give us some relative idea…
Dr. Nader Pourhassan
Yes. It could be as low as $3000 to $4000 per year treatment and that’s giving a patient two injections a week, which is too wild for us to provide for them.
(0)
(0)CytoDyn Inc (CYDY) Stock Research Links
Scroll down for more posts ▼